Ethan Korngold: I’m Excited by The New CREST-2 Trial Data Presented at SVIN2025, VEITH2025 and Published in NEJM
Ethan Korngold, Chief Medical Officer and DVP of Medical Affairs for the Abbott Vascular Business Unit, shared on LinkedIn:
”I’m excited by the new CREST-2 trial data presented at SVIN2025, VEITH2025 and published in NEJM adding an important chapter to understanding stroke prevention in patients with high-grade asymptomatic carotid stenosis.
In the stenting trial, carotid artery stenting (CAS) added to intensive medical therapy was associated with 2.8% stroke and death out to 4-years vs 6.0% for medical therapy.
The absolute difference of 3.2% favoring CAS was significant.
We are proud of the role our market leading carotid technologies including Xact and Emboshield NAV6, have in advancing research in stroke prevention.
These results will encourage the field to re-examine long-held assumptions about asymptomatic disease management.
As new evidence emerges, our responsibility is to interpret it carefully, understand where it applies, and continue refining strategies that support long-term patient outcomes.
My gratitude to the CREST-2 investigators for their commitment to a rigorous comparative study.
Read the abstract in NEJM.
Stay updated with Hemostasis Today.
-
Oct 22, 2026, 18:04Basem Goueli: Blood Clots in the NFL
-
Oct 22, 2026, 17:57Syed Ahmed: Viral Triggers of Immune Thrombocytopenia and Thrombosis
-
Oct 22, 2026, 17:49Valerie Tutwiler: Bridging Engineering and Medicine to Advance Thrombosis Research
-
Oct 22, 2026, 17:41Jesus Ardila Novoa: How Patient Education Can Transform Hemophilia Care
-
Oct 22, 2026, 17:30Filipe Gonçalves: Advancing Bleeding Disorder Diagnosis Through Multidisciplinary Collaboration
-
Oct 22, 2026, 17:17Storage Pool Deficiency An Overview of a Rare Platelet Disorder – EHC
-
Oct 22, 2026, 17:10Matthew Hazell: Optimizing the Use of Rare Red Blood Cell Units
-
Oct 22, 2026, 17:03Smita Patil: New Insights Into Platelet Alpha-Granule Secretion
-
Oct 22, 2026, 16:48Ahmed Alotaibi: Rare Rh Phenotype and Severe Fetal Anaemia